Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.250
+0.050 (4.17%)
At close: Sep 26, 2025, 4:00 PM EDT
1.230
-0.020 (-1.60%)
After-hours: Sep 26, 2025, 7:26 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Allogeneic T Cell Therapies
22.00K
Log In
Log In
Log In
Allogeneic T Cell Therapies Growth
-76.84%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
United States
22.00K
Log In
Log In
Log In
United States Growth
-76.84%
Log In
Log In
Log In